UBS ASSET MANAGEMENT AMERICAS LLC - VOYAGER THERAPEUTICS INC ownership

VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 127 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of VOYAGER THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$298,290
-99.8%
48,900
+86.4%
0.00%
Q1 2021$123,549,000
+23.3%
26,231
+87.2%
0.00%
Q4 2020$100,165,000
-33.0%
14,0090.0%0.00%
Q3 2020$149,476,000
-15.5%
14,0090.0%0.00%
Q2 2020$176,793,000
+37.9%
14,0090.0%0.00%
Q1 2020$128,182,000
-96.9%
14,009
-95.2%
0.00%
-100.0%
Q4 2019$4,100,966,000
-23.8%
293,976
-6.1%
0.00%
-25.0%
Q3 2019$5,385,371,000
-36.2%
312,921
+0.9%
0.00%
-33.3%
Q2 2019$8,440,433,000
+47.3%
310,082
+3.6%
0.01%
+50.0%
Q1 2019$5,730,402,000
+94.8%
299,394
-4.3%
0.00%
+33.3%
Q4 2018$2,941,251,000
-53.7%
312,899
-6.8%
0.00%
-40.0%
Q3 2018$6,350,895,000
-0.9%
335,671
+2.4%
0.01%0.0%
Q2 2018$6,405,798,000
+27.6%
327,830
+22.7%
0.01%
+25.0%
Q1 2018$5,018,847,000
+12.7%
267,102
-0.4%
0.00%0.0%
Q4 2017$4,451,373,000268,1550.00%
Other shareholders
VOYAGER THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TRV GP III, LLC 6,391,176$60,077,00050.34%
ARMISTICE CAPITAL, LLC 2,836,000$26,658,0002.02%
Casdin Capital, LLC 1,128,075$10,604,0001.81%
BB BIOTECH AG 2,865,841$26,939,0000.86%
HIGHLINE CAPITAL MANAGEMENT, L.P. 1,284,697$12,076,0000.81%
Aevitas Wealth Management, Inc. 48,300$454,0000.46%
GREAT POINT PARTNERS LLC 365,132$3,432,0000.43%
Patriot Financial Group Insurance Agency, LLC 61,320$576,0000.38%
HARBOURVEST PARTNERS LLC 72,726$684,0000.32%
Birchview Capital, LP 33,000$310,0000.29%
View complete list of VOYAGER THERAPEUTICS INC shareholders